ReferenceRRK5969

GS-US-428-4025

A Phase 2 Randomized Double-Blind Placebo-Controlled Study Evaluating the Safety Tolerability and Efficacy of GS-9674 in Subjects with Primary Sclerosing Cholangitis Without Cirrhosis

Research Summary

Research Overview
Sponsor Gilead Sciences
Project Status Open
Proposed End Date 13/02/2020
Study Run through CRF? Yes
Target number of patients agreed to recruit 2
Recruitment so far 1